|
市場調査レポート
商品コード
1473189
静脈ドレッシングの世界市場:市場規模、シェア、動向分析 - タイプ別、最終用途別、地域別展望、予測(2024~2031年)Global IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, and Translucent), By End-use (Hospitals, Clinics, and Others), By Regional Outlook and Forecast, 2024 - 2031 |
||||||
|
静脈ドレッシングの世界市場:市場規模、シェア、動向分析 - タイプ別、最終用途別、地域別展望、予測(2024~2031年) |
出版日: 2024年04月18日
発行: KBV Research
ページ情報: 英文 227 Pages
納期: 即納可能
![]() |
世界の静脈ドレッシングの市場規模は、予測期間中にCAGR 5.9%で成長し、2031年までに13億米ドルに達すると予測されています。2023年には、市場は4,495万900ユニットに達し、2020~2023年にかけて17.3%の成長を遂げました。
さらに、静脈ドレッシング市場は、ヘルスケア産業の他の多くの分野と同様に、パンデミックによるロックダウン、旅行制限、物流上の課題により、サプライチェーンの混乱を経験しました。メーカーは原材料の調達、生産の遅れ、流通のボトルネックで困難に直面し、一部の地域で静脈ドレッシングが不足しました。また、 COVID-19パンデミックにより、特に重症のCOVID-19患者の治療において、IV療法の需要が増加しました。IV療法は、呼吸困難、脱水症、またはウイルスによる合併症を経験している患者に、水分、薬剤、およびその他の救命治療を投与するために不可欠です。したがって、 COVID-19パンデミックは静脈ドレッシング市場に中程度の影響を及ぼしました。
しかし、自然災害、輸送の遅れ、製造上の問題などのサプライチェーンの混乱により、品不足や在庫切れが発生する可能性があります。ヘルスケア機関は患者のケアと治療をサポートするためにドレッシング材の安定した供給に依存しており、供給が中断すると臨床ワークフローが中断し、手順が遅れ、患者の安全が損なわれる可能性があります。したがって、サプライチェーンの混乱により、市場の成長が鈍化する可能性があります。
The Global IV Dressing Market size is expected to reach $1.3 Billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period. In the year 2023, the market attained a volume of 44,950.9 thousand units, experiencing a growth of 17.3% (2020-2023).
In 2023, the Asia Pacific region acquired a significant revenue share in the IV dressing market. The Asia Pacific region is seeing an upsurge in the frequency of chronic diseases like diabetes, cardiovascular disease, and cancer, owing primarily to urbanization, sedentary lifestyles, and changing dietary patterns. Therefore, the region is expected to generate 26.55% revenue share by 2031. Also, China would consume 6,159.7 thousand units of these dressings by 2031. The Asia Pacific region's economic expansion is causing governments and private sector organizations to invest more in enhancing healthcare infrastructure and broadening access to healthcare services, increasing healthcare spending.
Ambulatory care centers provide a wide range of medical treatments and procedures on an outpatient basis. Many of these procedures, such as infusion therapies, diagnostic tests, and minor surgeries, require IV access for medication administration. Therefore, the market is expanding significantly due to the expansion of ambulatory care centers. Additionally, Cancer patients frequently undergo chemotherapy or radiation therapy, which may require IV administration of chemotherapy drugs or supportive medications. Furthermore, cancer patients may require IV fluids or blood products to manage side effects such as dehydration or anemia. Thus, because of the growing prevalence of chronic diseases, the market is anticipated to increase significantly.
Moreover, The IV dressing market, like many other sectors of the healthcare industry, experienced disruptions in the supply chain due to lockdowns, travel restrictions, and logistical challenges caused by the pandemic. Manufacturers faced difficulties in sourcing raw materials, production delays, and distribution bottlenecks, leading to shortages of IV dressings in some regions. Also, The COVID-19 pandemic increased demand for IV therapy, notably in treating critically ill COVID-19 patients. IV therapy is crucial for administering fluids, medications, and other life-saving treatments to patients experiencing respiratory distress, dehydration, or complications from the virus. Thus, the COVID-19 pandemic had a moderate effect on the IV dressing market.
However, supply chain disruptions, like natural disasters, transportation delays, or manufacturing issues, can lead to shortages or stockouts. Healthcare institutions rely on a consistent supply of dressings to support patient care and treatment, and supply interruptions can disrupt clinical workflows, cause delays in procedures, and compromise patient safety. Thus, supply chain disruptions can slow down the growth of the market.
By Type Analysis
By type, the market is categorized as transparent and translucent. The translucent segment covered 25.23% considerable revenue share in the market in 2023 and in terms of volume the translucent segment consumes 8,418.6 thousand units in 2023. Translucent balance transparency and opacity, providing healthcare providers a partially clear view of the insertion site while offering some opacity for privacy and light protection. This versatility makes translucent dressings suitable for various clinical applications, driving their adoption across various healthcare settings. Translucent dressings are less noticeable on the skin than opaque dressings, providing a more aesthetically pleasing appearance for patients. The semi-transparent nature of translucent dressings allows for discreet monitoring of the insertion site while maintaining patient privacy and dignity, enhancing the overall patient experience.
By End-use Analysis
Based on end-use, the market is classified into hospitals, clinics, and others. The clinics segment acquired 32.13% revenue share in the market in 2023. In terms of volume, the clinics segment registered 13,373.8 thousand units in 2023. Clinics perform a wide range of outpatient procedures that require IV access for medication administration, fluid therapy, and diagnostic testing. As the trend towards outpatient care continues to grow, driven by convenience, cost-effectiveness, and advancements in medical technology, the demand for dressings in clinics rises accordingly.
By Regional Analysis
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the North America region led the market by generating 40.93% revenue share. North America has a significant population affected by chronic diseases like diabetes, cardiovascular diseases, and cancer. North America boasts advanced healthcare infrastructure with well-established hospitals, clinics, and ambulatory care centers with state-of-the-art facilities and technologies. The aging population in North America contributes to the demand for healthcare services, including IV therapy.
List of Key Companies Profiled
Global IV Dressing Market Report Segmentation
By Type (Volume, Thousand Units, USD Billion, 2020-2031)
By End-use (Volume, Thousand Units, USD Billion, 2020-2031)
By Geography (Volume, Thousand Units, USD Billion, 2020-2031)